Schizophrenia and suicide

East Asian Archives of Psychiatry

Volumn 22, Issue 3, 2012, Pages 126-133

  Balhara, Yatan Pal Singh ^a   Verma, R ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b DR RAM MANOHAR LOHIA HOSPITAL   (India)

Author keywords

Schizophrenia; Suicide

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; CLOZAPINE; EXCITATORY AMINO ACID TRANSPORTER 1; OLANZAPINE; QUETIAPINE; RISPERIDONE;

AWARENESS; DEPRESSION; FAMILY HISTORY; FAMILY STRESS; FEAR; HOPELESSNESS; HUMAN; MARRIAGE; MORTALITY; PSYCHOTHERAPY; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SEX DIFFERENCE; SOCIAL ISOLATION; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SUICIDE; SUICIDE ATTEMPT; SYSTEMATIC REVIEW; UNEMPLOYMENT;

ANTIPSYCHOTIC AGENTS; HUMANS; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUICIDE;

EID: 84867194633     PISSN: 20789947     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (86)

1. Preventing suicide - a resource for general physicians. Geneva: Mental and Behavioural Disorders, Department of Mental Health, World Health Organization; 2000. Website: http://www.who.int/mental-health/media/en/56.pdf. Accessed 17 Aug 2012.
2. Hendin H, Phillips MR, Vijayakumar L, Pirkis J, Wang H, Yip P, et al. Suicide and suicide prevention in Asia. Geneva: World Health Organization; 2008.
3. Bleuler E. Dementia praecox or the group of schizophrenias (trans. J. Zinkin). Zinkin J, editor. New York, NY: International Universities Press; 1950.
4. White J, Gray R, Jones M. The development of the serious mental illness physical Health Improvement Profile. J Psychiatr Ment Health Nurs 2009;16:493-8.
5. Sartorius N, Jablensky A, Korten A, Ernberg G, Anker M, Cooper JE, et al. Early manifestations and first-contact incidence of schizophrenia in different cultures. A preliminary report on the initial evaluation phase of the WHO Collaborative Study on determinants of outcome of severe mental disorders. Psychol Med 1986;16:909-28.
6. Alphs L, Anand R, Islam MZ, Meltzer HY, Kane JM, Krishnan R, et al. The international suicide prevention trial (interSePT): rationale and design of a trial comparing the relative ability of clozapine and olanzapine to reduce suicidal behavior in schizophrenia and schizoaffective patients. Schizophr Bull 2004;30:577-86. (Pubitemid 39625698)
7. Barraclough J, Gill D. Hughes' outline of modern psychiatry. 4th ed. Chichester: Wiley; 1996.
8. Gelder MG, Gath D, Mayou R. Oxford textbook of psychiatry. 2nd ed. Oxford: Oxford University Press; 1989.
9. Inskip HM, Harris EC, Barraclough B. Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia. Br J Psychiatry 1998;172:35-7. (Pubitemid 28122524)
10. Palmer BA, Pankratz VS, Bostwick JM. The lifetime risk of suicide in schizophrenia: a reexamination. Arch Gen Psychiatry 2005;62:247-53. (Pubitemid 40990969)
11. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007;64:1123-31. (Pubitemid 47529346)
12. Isometsä ET. Psychological autopsy studies - a review. Eur Psychiatry 2001;16:379-85. (Pubitemid 33101271)
13. Roy A, Draper R. Suicide among psychiatric hospital in-patients. Psychol Med 1995;25:199-202.
14. Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 1997;170:205-28. (Pubitemid 27117683)
15. Addington J, Williams J, Young J, Addington D. Suicidal behaviour in early psychosis. Acta Psychiatr Scand 2004;109:116-20. (Pubitemid 38186823)
16. Nordentoft M, Jeppesen P, Abel M, Kassow P, Petersen L, Thorup A, et al. OPUS study: suicidal behaviour, suicidal ideation and hopelessness among patients with first-episode psychosis. One-year follow-up of a randomised controlled trial. Br J Psychiatry Suppl 2002;43:s98-106.
17. Verdoux H, Liraud F, Gonzales B, Assens F, Abalan F, van Os J. Predictors and outcome characteristics associated with suicidal behaviour in early psychosis: a two-year follow-up of first-admitted subjects. Acta Psychiatr Scand 2001;103:347-54. (Pubitemid 32436747)
18. Landmark J, Cernovsky ZZ, Merskey H. Correlates of suicide attempts and ideation in schizophrenia. Br J Psychiatry 1987;151:18-20. (Pubitemid 17117619)
19. Planansky K, Johnston R. The occurrence and characteristics of suicidal preoccupation and acts in schizophrenia. Acta Psychiatr Scand 1971;47:473-83.
20. Roy A, Mazonson A, Pickar D. Attempted suicide in schizophrenia. Br J Psychiatry 1984;144:303-6.
21. Breier A, Schreiber JL, Dyer J, Pickar D. National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome. Arch Gen Psychiatry 1991;48:239-46.
22. Weiden P, Roy A. General versus specific risk factors for suicide in schizophrenia. In: Jacobs D, editor. Suicide and clinical practice. Washington, DC: American Psychiatric Press; 1992: 75-100.
23. Taiminen TJ, Kujari H. Antipsychotic medication and suicide risk among schizophrenic and paranoid inpatients. A controlled retrospective study. Acta Psychiatr Scand 1994;90:247-51. (Pubitemid 24303591)
24. Caldwell CB, Gottesman II. Schizophrenics kill themselves too: a review of risk factors for suicide. Schizophr Bull 1990;16:571-89.
25. Allebeck P, Varia A, Wistedt B. Suicide and violent death among patients with schizophrenia. Acta Psychiatr Scand 1986;74:43-9. (Pubitemid 16061286)
26. Black DW. The Iowa record-linkage experience. Suicide Life Threat Behav 1989;19:78-89. (Pubitemid 19104710)
27. Mortensen PB, Juel K. Mortality and causes of death in first admitted schizophrenic patients. Br J Psychiatry 1993;163:183-9. (Pubitemid 23233086)
28. Fenton WS, McGlashan TH, Victor BJ, Blyler CR. Symptoms, subtype, and suicidality in patients with schizophrenia spectrum disorders. Am J Psychiatry 1997;154:199-204. (Pubitemid 27053725)
29. Hawton K, Sutton L, Haw C, Sinclair J, Deeks JJ. Schizophrenia and suicide: systematic review of risk factors. Br J Psychiatry 2005;187:9-20. (Pubitemid 41002508)
30. Cohen LJ, Test MA, Brown RL. Suicide and schizophrenia: data from a prospective community treatment study. Am J Psychiatry 1990;147:602-7. (Pubitemid 20153430)
31. Hawton K. Sex and suicide. Gender differences in suicidal behaviour. Br J Psychiatry 2000;177:484-5. (Pubitemid 32005476)
32. Rogers P, Watt A, Gray NS, MacCulloch M, Gournay K. Content of command hallucinations predicts self-harm but not violence in a medium secure unit. J Forensic Psychiatry 2002;13:251-62.
33. Hellerstein D, Frosch W, Koenigsberg HW. The clinical significance of command hallucinations. Am J Psychiatry 1987;144:219-21. (Pubitemid 17011400)
34. Rudnick A. Relation between command hallucinations and dangerous behavior. J Am Acad Psychiatry Law 1999;27:253-7. (Pubitemid 29289796)
35. Zisook S, Byrd D, Kuck J, Jeste DV. Command hallucinations in outpatients with schizophrenia. J Clin Psychiatry 1995;56:462-5.
36. Siris SG, Addington D, Azorin JM, Falloon IR, Gerlach J, Hirsch SR. Depression in schizophrenia: recognition and management in the USA. Schizophr Res 2001;47:185-97. (Pubitemid 32244103)
37. Conley RR, Ascher-Svanum H, Zhu B, Faries D, Kinon BJ. The burden of depressive symptoms in the long-term treatment of patients with schizophrenia. Schizophr Res 2007;90:186-97. (Pubitemid 46177554)
38. Siris SG. Suicide and schizophrenia. J Psychopharmacol 2001;15:127-35. (Pubitemid 32619590)
39. Goodwin R, Lyons JS, McNally RJ. Panic attacks in schizophrenia. Schizophr Res 2002;58:213-20. (Pubitemid 35284512)
40. Shuwall M, Siris SG. Suicidal ideation in postpsychotic depression. Compr Psychiatry 1994;35:132-4. (Pubitemid 24089837)
41. Roy A. Suicide in chronic schizophrenia. Br J Psychiatry 1982;141:171-7. (Pubitemid 12092788)
42. Kim CH, Jayathilake K, Meltzer HY. Hopelessness, neurocognitive function, and insight in schizophrenia: relationship to suicidal behavior. Schizophr Res 2003;60:71-80. (Pubitemid 36015789)
43. Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, Bertoldi A, et al. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry 2003;60:82-91. (Pubitemid 36070868)
44. Warnes H. Suicide in schizophrenics. Dis Nerv Syst 1968;29 Suppl:35-40.
45. Bourgeois M, Swendsen J, Young F, Amador X, Pini S, Cassano GB, et al. Awareness of disorder and suicide risk in the treatment of schizophrenia: results of the international suicide prevention trial. Am J Psychiatry 2004;161:1494-6. (Pubitemid 38989107)
46. Nicholas LM, Golden RN. Managing the suicidal patient. Clin Cornerstone 2001;3:47-57.
47. Mortensen PB, Agerbo E, Erikson T, Qin P, Westergaard-Nielsen N. Psychiatric illness and risk factors for suicide in Denmark. Lancet 2000;355:9-12. (Pubitemid 30072176)
48. Appleby L, Shaw J, Amos T, McDonnell R, Harris C, McCann K, et al. Suicide within 12 months of contact with mental health services: national clinical survey. BMJ 1999;318:1235-9. (Pubitemid 29210051)
49. Ho TP. The suicide risk of discharged psychiatric patients. J Clin Psychiatry 2003;64:702-7.
50. Pirkola S, Sohlman B, Wahlbeck K. The characteristics of suicides within a week of discharge after psychiatric hospitalisation - a nationwide register study. BMC Psychiatry 2005;5:32.
51. King EA, Baldwin DS, Sinclair JM, Campbell MJ. The Wessex Recent In-Patient Suicide Study, 2. Case-control study of 59 in-patient suicides. Br J Psychiatry 2001;178:537-42. (Pubitemid 32531747)
52. Drake RE, Ehrlich J. Suicide attempts associated with akathisia. Am J Psychiatry 1985;142:499-501. (Pubitemid 15108220)
53. Shear MK, Frances A, Weiden P. Suicide associated with akathisia and depot fluphenazine treatment. J Clin Psychopharmacol 1983;3:235-6. (Pubitemid 13047646)
54. Shaw ED, Mann JJ, Weiden PJ, Sinsheimer LM, Brunn RD. A case of suicidal and homicidal ideation and akathisia in a double-blind neuroleptic crossover study. J Clin Psychopharmacol 1986;6:196-7.
55. Cem Atbaşoglu E, Schultz SK, Andreasen NC. The relationship of akathisia with suicidality and depersonalization among patients with schizophrenia. J Neuropsychiatry Clin Neurosci 2001;13:336-41. (Pubitemid 32743711)
56. Cheng KK, Leung CM, Lo WH, Lam TH. Risk factors of suicide among schizophrenics. Acta Psychiatr Scand 1990;81:220-4. (Pubitemid 20161219)
57. Nuechterlein KH, Dawson ME. A heuristic vulnerability / stress model of schizophrenic episodes. Schizophr Bull 1984;10:300-12.
58. Mann JJ, Oquendo M, Underwood MD, Arango V. The neurobiology of suicide risk: a review for the clinician. J Clin Psychiatry 1999;60 Suppl 2:7-11. (Pubitemid 29101957)
59. Kim S, Choi KH, Baykiz AF, Gershenfeld HK. Suicide candidate genes associated with bipolar disorder and schizophrenia: an exploratory gene expression profiling analysis of post-mortem prefrontal cortex. BMC Genomics 2007;8:413.
60. Souza RP, De Luca V, Manchia M, Kennedy JL. Are serotonin 3A and 3B receptor genes associated with suicidal behavior in schizophrenia subjects? Neurosci Lett 2011;489:137-41.
61. Correa H, De Marco L, Boson W, Nicolato R, Teixeira AL, Campo VR, et al. Association study of T102C 5-HT(2A) polymorphism in schizophrenic patients: diagnosis, psychopathology, and suicidal behavior. Dialogues Clin Neurosci 2007;9:97-101. (Pubitemid 46607135)
62. Molnar S, Mihanović M, Grah M, Kezić S, Filaković P, Degmecić D. Comparative study on gene tags of the neurotransmission system in schizophrenic and suicidal subjects. Coll Antropol 2010;34:1427-32.
63. Mimics K, Levitt P, Lewis DA. Critical appraisal of DNA microarrays in psychiatric genomics. Biol Psychiatry 2006;60:163-76.
64. Hamasaki T, Leingärtner A, Ringstedt T, O'Leary DD. EMX2 regulates sizes and positioning of the primary sensory and motor areas in neocortex by direct specification of cortical progenitors. Neuron 2004;43:359-72. (Pubitemid 39061128)
65. Must A, Tasa G, Lang A, Vasar E, Kõks S, Maron E, et al. Association of limbic system-associated membrane protein (LSAMP) to male completed suicide. BMC Med Genet 2008;9:34.
66. Bradley AJ, Dinan TG. A systematic review of hypothalamic-pituitary- adrenal axis function in schizophrenia: implications for mortality. J Psychopharmacol 2010;24(4 Suppl):91-118.
67. Jones JS, Stein DJ, Stanley B, Guido JR, Winchel R, Stanley M. Negative and depressive symptoms in suicidal schizophrenics. Acta Psychiatr Scand 1994;89:81-7. (Pubitemid 24047670)
68. Płocka-Lewandowska M, Araszkiewicz A, Rybakowski JK. Dexamethasone suppression test and suicide attempts in schizophrenic patients. Eur Psychiatry 2001;16:428-31. (Pubitemid 33101279)
69. Pompili M, Mancinelli I, Tatarelli R. GPs' role in the prevention of suicide in schizophrenia. Fam Pract 2002;19:221. (Pubitemid 34567643)
70. Kessler RC, Borges G, Walters EE. Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey. Arch Gen Psychiatry 1999;56:617-26. (Pubitemid 29315633)
71. Beisser AR, Blanchette JE. A study of suicides in a mental hospital. Dis Nerv Syst 1961;22:365-9.
72. Hussar AE. Effect of tranquilizers on medical morbidity and mortality in a mental hospital. JAMA 1962;179:682-6.
73. Johnson DA, Pasterski G, Ludlow JM, Street K, Taylor RD. The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients: drug and social consequences. Acta Psychiatr Scand 1983;67:339-52. (Pubitemid 13079179)
74. Cohen S, Leonard CV, Farberow NL, Shneidman ES. Tranquilizers and suicide in the schizophrenic patient. Arch Gen Psychiatry 1964;11:312-21.
75. Kline NS. Psychopharmaceuticals: effects and side effects. Bull World Health Organ 1959;21:397-410.
76. Khan A, Khan SR, Leventhal RM, Brown WA. Symptom reduction and suicide risk among patients treated with placebo in antipsychotic clinical trials: an analysis of the food and drug administration database. Am J Psychiatry 2001;158:1449-54. (Pubitemid 32847244)
77. Keck PE Jr, Strakowski SM, McElroy SL. The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia. J Clin Psychiatry 2000;61 Suppl 3:4-9. (Pubitemid 30155227)
78. Meltzer HY. Treatment of suicidality in schizophrenia. Ann N Y Acad Sci 2001;932:44-58.
79. Barak Y, Mirecki I, Knobler HY, Natan Z, Aizenberg D. Suicidality and second generation antipsychotics in schizophrenia patients: a case-controlled retrospective study during a 5-year period. Psychopharmacology (Berl) 2004;175:215-9. (Pubitemid 39222352)
80. Sernyak MJ, Desai R, Stolar M, Rosenheck R. Impact of clozapine on completed suicide. Am J Psychiatry 2001;158:931-7. (Pubitemid 32547624)
81. Munro J, O'Sullivan D, Andrews C, Arana A, Mortimer A, Kerwin R. Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance. Br J Psychiatry 1999;175:576-80.
82. Reid WH, Mason M, Hogan T. Suicide prevention effects associated with clozapine therapy in schizophrenia and schizoaffective disorder. Psychiatr Serv 1998;49:1029-33. (Pubitemid 28363821)
83. Walker AM, Lanza LL, Arellano F, Rothman KJ. Mortality in current and former users of clozapine. Epidemiology 1997;8:671-7. (Pubitemid 27449500)
84. Meltzer HY, Okayli G. Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment. Am J Psychiatry 1995;152:183-90.
85. Cotton PG, Drake RE, Gates C. Critical treatment issues in suicide among schizophrenics. Hosp Community Psychiatry 1985;36:534-6. (Pubitemid 15075080)
86. Drake RE, Wallach MA, Hoffman JS. Housing instability and homelessness among aftercare patients of an urban state hospital. Hosp Community Psychiatry 1989;40:46-51. (Pubitemid 19029898)